Epidemiology of canine leishmaniasis: prevalence, incidence and basic reproduction number calculated from a cross-sectional serological survey on the island of Gozo, Malta.
Assessment of the resilience of canine leishmaniasis to control or, more ambitiously, the effort needed to eradicate infection, requires an estimate of the basic case reproduction number (R0). This paper applies the theoretical results of Hasibeder, Dye & Carpenter (1992) to data from a cross-sectional survey on the Maltese island of Gozo in which dogs of known age, sex and occupation (pet, guard etc) were subjected to three different serological tests for the presence of specific antibody (IFAT, DAT and ELISA). Difficulties in interpreting these test results, and hence of determining the proportion of dogs infected, present the main obstacle to estimating R0: estimates are critically dependent on the choice of threshold separating seropositives from seronegatives. The data do, however, allow a robust comparative analysis of risk which shows that the force of infection experienced by working dogs is about three times higher than that of pet dogs, a degree of non-homogeneous contact which actually has little effect on estimates of R0. We suggest a cautious point estimate of R0 congruent to 11, and comment briefly on its significance for leishmaniasis control.
Dye
C
C
Department of Medical Parasitology, London School of Hygiene and Tropical Medicine, UK.
Killick-Kendrick
R
R
Vitutia
M M
MM
Walton
R
R
Killick-Kendrick
M
M
Harith
A E
AE
Guy
M W
MW
Cañavate
M C
MC
Hasibeder
G
G
D000367:Age Factors; D000372:Agglutination Tests; D000818:Animals; D000831:Animals, Newborn; D000913:Antibodies, Protozoan / Q000097:blood*; D050936:Basic Reproduction Number; D003430:Cross-Sectional Studies; D004198:Disease Susceptibility; D004283:Dog Diseases / Q000453:epidemiology*; D004285:Dogs; D004797:Enzyme-Linked Immunosorbent Assay; D005247:Feeding Behavior; D005260:Female; D005455:Fluorescent Antibody Technique; D015994:Incidence; D007303:Insect Vectors / Q000502:physiology; D007893:Leishmania donovani / Q000276:immunology*; D007898:Leishmaniasis, Visceral / Q000175:diagnosis / Q000453:epidemiology / Q000662:veterinary*; D008017:Life Expectancy; D008297:Male; D008319:Malta / Q000453:epidemiology; D010691:Phlebotomus / Q000502:physiology; D015995:Prevalence; D011336:Probability; D012680:Sensitivity and Specificity
D000913:Antibodies, Protozoan